Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
50.45
+0.37 (0.74%)
Jul 31, 2026, 3:04 PM CST

Intco Medical Technology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
5,9645,94812,0147,2225,0335,003
Short-Term Investments
---723.211,613-
Trading Asset Securities
6,9007,2436,7375,2361,6243,274
Cash & Short-Term Investments
12,86413,19118,75113,1818,2708,277
Cash Growth
-38.70%-29.65%42.26%59.39%-0.09%29.52%
Accounts Receivable
1,3341,3711,379937.18555.36775.15
Other Receivables
16.9946.0878.3341.8980.9330.6
Receivables
1,3511,4171,457979.08636.29805.75
Inventory
1,6941,3271,2651,1501,0041,079
Other Current Assets
521.14363.99480.62292.93325.23600.95
Total Current Assets
16,43016,29921,95515,60310,23510,763
Property, Plant & Equipment
11,60911,6079,7909,2468,9118,262
Long-Term Investments
10,55510,4611,382970.38884.94473.89
Other Intangible Assets
716.94729.1767.03566.84583.48629.91
Long-Term Deferred Tax Assets
51.6151.6180.3564.0988.3177.23
Long-Term Deferred Charges
4.844.925.221.841.762.9
Other Long-Term Assets
931.48937.67651.63627.32774.31415.84
Total Assets
40,30040,09034,63127,07921,47920,625

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,3681,257845.38921.6946.361,238
Accrued Expenses
120.54234.47215.38174.47201.53194
Short-Term Debt
16,40216,39012,6667,0341,49450.48
Current Portion of Long-Term Debt
917.55701.44436.3753.429.0434.29
Current Portion of Leases
---1.944.012.64
Current Income Taxes Payable
165.29116.4165.1815.649.6337.5
Current Unearned Revenue
249.84237271.58293.6300.89414.16
Other Current Liabilities
257.14241.9182.41123.67169.43113.07
Total Current Liabilities
19,48119,17814,6838,6183,1552,084
Long-Term Debt
322.89409.29166.877.2551.59201.26
Long-Term Leases
----1.783.38
Long-Term Unearned Revenue
207.42211.99155.84123.99128.53201.02
Long-Term Deferred Tax Liabilities
1,7191,7191,9441,9652,0932,012
Total Liabilities
21,73021,51916,94910,7855,4294,501

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
654.75654.75646.19656659.55549.58
Additional Paid-In Capital
1,1831,1831,1141,2871,3101,509
Retained Earnings
16,70216,69215,77814,39614,07213,855
Treasury Stock
-239.12-239.12-133.47-320.55-253.81-27.76
Comprehensive Income & Other
-50.71-36.68-0.3810.6318.79-15.22
Total Common Equity
18,25018,25417,40416,02915,80615,871
Minority Interest
319.59318.06277.6265.99242.93252.25
Shareholders' Equity
18,56918,57217,68216,29516,04916,123
Total Liabilities & Equity
40,30040,09034,63127,07921,47920,625

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
17,64317,50113,2697,1661,580292.05
Net Cash (Debt)
-4,778-4,3105,4826,0156,6897,985
Net Cash Growth
---8.86%-10.08%-16.23%30.68%
Net Cash Per Share
-7.85-6.698.459.1110.1011.82
Filing Date Shares Outstanding
501.54646.16641.39643.38659.55659.49
Total Common Shares Outstanding
501.54646.16641.39643.38659.55659.49
Working Capital
-3,051-2,8797,2726,9857,0808,679
Book Value Per Share
36.3928.2527.1424.9123.9724.07
Tangible Book Value
17,53317,52516,63715,46215,22315,241
Tangible Book Value Per Share
34.9627.1225.9424.0323.0823.11
Land
-11.7211.7211.7211.5210.55
Buildings
-5,8874,5574,0573,4802,400
Machinery
-8,4716,6245,6134,9864,247
Construction In Progress
-803.111,2881,5091,7052,326